Kincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
Read MoreKincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
Read MoreeXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Kincell Bio, a contract development and manufacturing organization (CDMO) focused on cell therapies, today announced the formation of a new global partnership for a breadth of advanced therapy manufacturing services. This partnership seamlessly brings together both companies’ CGT manufacturing capabilities in Europe and the US. Customers can now access a global development and manufacturing footprint in combination with the boutique customer-focused offerings of both companies. Key collaboration features include: Vast Capabilities: The partnership promises a seamless fusion of their distinctive strengths, presenting a suite of services for both […]
Read MoreA small CDMO called Kincell Bio launched Wednesday, with its CEO hoping to fill a niche offering cell therapy manufacturing for early-stage biotech startups.
Read MoreKincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in new funding. Kineticos Ventures led Kincell’s launch funding. Kincell is a spinout of Inceptor Bio’s CMC, manufacturing and quality organizations formed to accelerate innovator research and clinical trials. Kincell acquires a facility and a fully staffed team based at its Gainesville site, with plans to grow in Gainesville, as well as in additional key markets, such as Research Triangle Park (RTP), Boston and other customer locations. Kincell offers analytical development, process development, CMC consulting and early-stage GMP manufacturing […]
Read MoreKincell Bio is attending Meeting on the Mesa. Schedule some time to learn more about us.
Learn More